LI Fen
Impact in
-
- Chronic Kidney Disease and Diabetes
- Gout, Hyperuricemia, Uric Acid
- Dialysis and Renal Disease Management
Papers in
-
- Dialysis and Renal Disease Management 4
- Chronic Kidney Disease and Diabetes 2
-
- Congenital Heart Disease Studies 3
- Sepsis Diagnosis and Treatment 1
- Co-authors
- Min Tan (1 shared paper)Sheng Chen (1 shared paper)Min Wang (1 shared paper)Jing Wu (1 shared paper)Xiaohua Pei (2 shared papers)Xiaoxuan Zhang (2 shared papers)Yanfen Wang (1 shared paper)Weihong Zhao (2 shared papers)
- Journals
- Annals of Palliative Medicine (1 paper)Chinese Journal of Integrative Medicine (1 paper)DNA and Cell Biology (1 paper)International Immunopharmacology (1 paper)Diabetes Metabolic Syndrome and Obesity (1 paper)
- Partner nations
- China
In The Last Decade
LI Fen
18 papers receiving 77 citations
Peers
Comparison fields: 5 of 56
- Nephrology 35
- Immunology and Allergy 4
- Epidemiology 20
- Orthopedics and Sports Medicine 4
- Biological Psychiatry 1
Countries citing papers authored by LI Fen
This map shows the geographic impact of LI Fen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LI Fen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LI Fen more than expected).
Fields of papers citing papers by LI Fen
This network shows the impact of papers produced by LI Fen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LI Fen. The network helps show where LI Fen may publish in the future.
Co-authors
The 25 scholars most cited alongside LI Fen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 24 | |
| 2 | 2018 | 12 | |
| 3 | 2017 | 7 | |
| 4 | 2014 | 6 | |
| 5 | 2021 | 5 | |
| 6 | Experimental research of the immunoregulatory action of polysaccharides of Lily. | 2010 | 3 |
| 7 | 2016 | 3 | |
| 8 | 2021 | 3 | |
| 9 | 2007 | 3 | |
| 10 | Roasting oxidation-thiosulfate leaching of gold from refractory gold-bearing sulfur concentrates | 2014 | 2 |
| 11 | Analysis on the causes of early neonatal death in Shanghai from 1999 to 2008 | 2010 | 2 |
| 12 | 2023 | 2 | |
| 13 | 2023 | 2 | |
| 14 | [Clinical diagnosis of anomalous origin of the left coronary artery from the pulmonary artery in 22 cases]. | 2008 | 2 |
| 15 | Diagnostic and Prognostic Value of Salivary MiR-10b for Esophageal Cancer | 2016 | 1 |
| 16 | [Evaluation of physiological index on treadmill exercise testing of 294 healthy children in Shanghai area]. | 2003 | 1 |
| 17 | 2006 | 1 | |
| 18 | [Arrhythmia in the long-term follow-up after intracardiac repair of tetralogy of Fallot]. | 2003 | 1 |
| 19 | 2021 | 1 | |
| 20 | 2022 | 0 |
About LI Fen
LI Fen is a scholar working on Nephrology, Epidemiology, Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine, having authored 20 papers that have together received 81 indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (4 papers), Congenital Heart Disease Studies (3 papers), Allergic Rhinitis and Sensitization (2 papers), Coronary Artery Anomalies (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Sepsis Diagnosis and Treatment (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Nephrology (35 citations), Immunology and Allergy (4 citations), Epidemiology (20 citations), Orthopedics and Sports Medicine (4 citations) and Biological Psychiatry (1 citation). LI Fen has collaborated with scholars based in China. Frequent co-authors include Min Tan, Sheng Chen, Min Wang, Jing Wu, Xiaohua Pei, Xiaoxuan Zhang, Yanfen Wang, Weihong Zhao, Dan Song and Xun Liu. Their work appears in journals such as Annals of Palliative Medicine, Chinese Journal of Integrative Medicine, DNA and Cell Biology, International Immunopharmacology and Diabetes Metabolic Syndrome and Obesity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.